Related Experiment Video
Updated: Jun 26, 2025
05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.5K
Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and
Li Long1, Han Zhang1, ZhiHui Zhou1
1Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, 605 Fenglin Road, Nanchang, Jiangxi, 330013, China.
European Journal of Medicinal Chemistry
|May 19, 2024
Summary
Pyrrole derivatives show promise as potent anti-cancer drugs, targeting cancer cells with high efficacy and minimal toxicity. This review explores their mechanisms, activities, and structure-activity relationships for developing novel cancer therapies.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Cancer remains a major global health challenge, necessitating the development of effective and safe anti-cancer agents.
- Pyrrole and its derivatives are recognized for their diverse pharmacological properties and potential in cancer treatment.
Purpose of the Study:
- To review recent advancements in pyrrole-based anti-cancer drug research.
- To elucidate the mechanisms of action, biological activities, and structure-activity relationships of pyrrole derivatives.
Main Methods:
- Literature review of recent scientific publications on pyrrole derivatives as anti-cancer agents.
- Analysis of reported data on mechanisms of action, biological activity, and structure-activity relationships.
Main Results:
- Pyrrole derivatives exhibit significant anti-cancer activity by targeting various cellular pathways.
- Several pyrrole-based compounds are in clinical trials, demonstrating their therapeutic potential.
- Structure-activity relationship studies provide insights into optimizing drug design.
Conclusions:
- Pyrrole serves as a valuable scaffold for developing novel anti-cancer drugs with improved efficacy and safety profiles.
- Further research into pyrrole derivatives can lead to innovative treatments for various cancers.
Related Concept Videos
01:13Five-Membered Heterocyclic Aromatic Compounds: Overview
3.9K
Heterocyclic aromatic compounds are cyclic compounds that are aromatic and have one or more heteroatoms—atoms other than carbon, in the ring. Depending upon the number of atoms present in the ring, they can be either five or six-membered. Examples of five-membered heterocyclic aromatic compounds include pyrrole, furan, thiophene, and imidazole. Pyrrole consists of one nitrogen atom having one lone pair of electrons. Furan and thiophene have one oxygen and one sulfur heteroatom,...
3.9K
01:25Basicity of Heterocyclic Aromatic Amines
6.0K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.0K
01:26Physical Properties of Amines
3.1K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.1K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K